Forecasted COVID-19 vaccine share of total mRNA revenues globally 2021-2035
In 2028, around 86 percent of all forecasted revenue of mRNA products is expected to be from COVID-19 vaccines. This statistic illustrates the share of COVID-19 vaccine revenue of total forecasted revenues from mRNA products worldwide from 2021 to 2035.